Wioletta Pawlukowska

Dr. Wioletta Pawlukowska

Pomeranian Medical University in Szczecin, Department of Aesthetic Dermatology
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
IRIwona Rotter
Iwona Rotter
ARAleksadnra Rył
Aleksadnra Rył
KGKatarzyna Grzesiak
Katarzyna Grzesiak
ASAleksandra Szylińska
Aleksandra Szylińska
WPWioletta Pawlukowska
Wioletta Pawlukowska
MLMaria Laszczyńska
Maria Laszczyńska
Introduction/Objective: The aim of the study was to show which of the adipose tissue accumulation indicators correlate with testosterone disorders in non-diabetic aging men. Material and methods: 455 non diabetic men, recruited at primary care facilities, aged 50–75 participated in the study. The participants underwent anthropometric measurement and ELISA determination of total testosterone (TT), estradiol (E2), dehydroepiandrosterone sulphate (DHEA-S), sex hormone binding protein (SHBG), and the determination of fasting glucose (FPG), high-density lipids cholesterol (HDL-Ch), and triacylglycerols (TAG) in serum. The following indicators were calculated: body mass index (BMI), waist-to-hip ratio (WHR), lipid accumulation product (LAP), and visceral adiposity index (VAI). Results: Men with testosterone deficiency syndrome (TDS) differed in each of the assessed obesity indices from those without TDS. All of the studied parameters correlated significantly negatively with TT concentration in blood serum, with VAI being the strongest predictor of TDS. It was shown that the threshold value at which the risk of TDS increased was 28.41 kg/m2 for BMI, 1.58 for VAI, 104 cm for WC, and 37.01 for LAP. Conclusions: Indicators of fat accumulation that take into account biochemical parameters in assessing lipid metabolism are better markers of actual body fat deposition than indicators based solely on anthropometric measurements. Among them, VAI seems the most suitable biomarker of TDS in non-diabetic aging men.

1 September 2015 in Neurologia i Neurochirurgia Polska
Verified
Journal Article
Closed access
WPWioletta Pawlukowska
Wioletta Pawlukowska
MGMONIKA GOŁĄB-JANOWSKA
MONIKA GOŁĄB-JANOWSKA
KSKrzysztof Safranow
Krzysztof Safranow
IRIwona Rotter
Iwona Rotter
KAKatarzyna Amernik
Katarzyna Amernik
PNPrzemysław Nowacki
Przemysław Nowacki
Parkinson's disease (PD) is one of the most common diseases of the central nervous system (CNS). It is frequently heralded by speech disturbances, which are one of its first symptoms. The aim of this paper is to share our own experience concerning the correlation between the severity of speech disorders and the PD duration, its severity and the intake of L-dopa. The research included 93 patients with idiopathic PD, aged 26-86 years (mean age 65.1 years). Participants were examined neurologically according to the Unified Parkinson's Disease Rating Scale (UPDRS) and the Hoehn and Yahr Scale. They were also assessed by Frenchay Dysarthria Assessment. Considerable and severe disorders were concurrent with impairments in the mobility of the tongue, lips, the jaw as well as the pitch and loudness of the voice. The strongest correlation but at a moderate level was found to exist between the severity of labial impairment, voice loudness and the length of the disease. There was also a positive correlation between lip movement while the motions were being diversified, lip arrangement while speaking and the intake of L-dopa. As PD progresses a significant decline in vocal articulation can be observed, which is due to reduced mobility within the lips and the jaw. Exacerbation of articulation disorders resulting from progression of the disease does not materially influence the UPDRSS scores. L-dopa has been found to positively affect the mobility of the lips while the patient is speaking and their arrangement at rest.

1 November 2018 in Journal of Voice
Verified
Journal Article
Closed access
WPWioletta Pawlukowska
Wioletta Pawlukowska
ASAleksandra Szylińska
Aleksandra Szylińska
DKDariusz Kotlęga
Dariusz Kotlęga
IRIwona Rotter
Iwona Rotter
PNPrzemysław Nowacki
Przemysław Nowacki

19 October 2019 in BMC Neurology
Verified
Journal Article
Open access
PDF file
WPWioletta Pawlukowska
Wioletta Pawlukowska
BBBartłomiej Baumert
Bartłomiej Baumert
MGMonika Gołąb-Janowska
Monika Gołąb-Janowska
AMAgnieszka Meller
Agnieszka Meller
KMKarolina Machowska-Sempruch
Karolina Machowska-Sempruch
PNPrzemysław Nowacki
Przemysław Nowacki
Background: Amyotrophic lateral sclerosis (ALS) is a fatal degenerative disease of a rapid course. In 25% of ALS sufferers, speech disorders occur as prodromal symptoms of the disease. Impaired communication affects physical health and has a negative impact on mental and emotional condition. In this study, we assessed which domains of speech are particularly affected in ALS. Subsequently, we estimated possible correlations between the ALS patients’ subjective perception of their speech quality and an objective assessment of the speech organs carried out by an expert. Methods: The study group consisted of 63 patients with sporadic ALS. The patients were examined for articulatory functions by means of Voice Handicap Index (VHI) and the Frenchay Dysarthria Assessment (FDA). Results: On the basis of the VHI scores, the entire cohort was divided into 2 groups: group I (40 subjects) with mild speech impairment, and group II (23 subjects) displaying moderate and profound speech deficits. In an early phase of ALS, changes were typically reported in the tongue, lips and soft palate. The FDA and VHI-based measurements revealed a high, positive correlation between the objective and subjective evaluation of articulation quality. Conclusions: Deterioration of the articulatory organs resulted in the reduction of social, physical and emotional functioning. The highly positive correlation between the VHI and FDA scales seems to indicate that the VHI questionnaire may be a reliable, self-contained tool for monitoring the course and progression of speech disorders in ALS. Trial registration: NCT02193893.

1 September 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KMKrystian Mross
Krystian Mross
MJMarta Jankowska
Marta Jankowska
AMAgnieszka Meller
Agnieszka Meller
KMKarolina Machowska-Sempruch
Karolina Machowska-Sempruch
PNPrzemysław Nowacki
Przemysław Nowacki
WPWioletta Pawlukowska
Wioletta Pawlukowska
Sensory integration disorder (SID) is also called, interchangeably, sensory processing disorder (SPD). Multiple sclerosis (MS) is an autoimmune, chronic, neurological disease of the central nervous system. Sensorimotor function disorders are present in both multiple sclerosis and SID. The study aimed to assess the SID among patients with MS and included 141 patients with relapse-remitting MS and 72 participants in the control group. To assess SID in both groups, a questionnaire prepared by Daniel Travis was used. Additionally, participants answered questions regarding their age, gender, handedness and in the study group about the duration of the disease, relapses in the past year and the advancement of the disease using EDSS. The occurrence of sensory seeking was significantly more frequent in the MS patients with relapses in the past year. Patients with MS had more often general disorders of sensory integration in the past. However, healthy subjects significantly more often showed the severity of social and emotional disorders in the past. Currently, the group of MS patients has a greater intensity of sensor-based motor abilities. The study revealed more severe SID in MS patients than in the control group. Still, more research is needed in this field.

1 August 2020 in Cells
Verified
Journal Article
Open access
PDF file
BBBartłomiej Baumert
Bartłomiej Baumert
ASAnna Sobuś
Anna Sobuś
MGMONIKA GOŁĄB-JANOWSKA
MONIKA GOŁĄB-JANOWSKA
EPEdyta Paczkowska
Edyta Paczkowska
KŁKarolina Łuczkowska
Karolina Łuczkowska
BMBogusław Machaliński
Bogusław Machaliński
Therapeutic interventions in amyotrophic lateral sclerosis (ALS) are still far from satisfying. Immune modulating procedures raise hopes for slowing the disease progression. Stem cell therapies are believed to possess the ability to regulate innate and adaptive immune response and inflammation processes. Hence, three intrathecal administrations of autologous bone marrow-derived lineage-negative (Lin–) cells were performed every six weeks in 40 sporadic ALS patients. The concentrations of inflammatory-related proteins and expression profiles of selected miRNA in the cerebrospinal fluid (CSF) and plasma at different timepoints post-transplantation were quantified by multiplex Luminex and qRT-PCR. The global gene expression in nucleated blood cells was assessed using the gene microarray technique. According to the ALS Functional Rating Scale (FRSr), the study population was divided into responders (group I, n = 17) and non-responders (group II, n = 23). A thorough analysis of the pro-inflammatory expression profiles, regulated miRNA pathways, and global gene expression profiles at the RNA level revealed the local and systemic effects of Lin– cell therapy on the immune system of patients with ALS. The autologous application of Lin– cells in CSF modulates immune processes and might prevent the progression of neurodegeneration. However, further in-depth studies are necessary to confirm the findings, and prolonged intervention is needed to maintain therapeutic effects.